Unexpected insights for anti-EGFR cancer therapy

被引：2
|
作者：
Depeille, Philippe [1 ]
Warren, Robert S. [1 ]
Roose, Jeroen P. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
来源：
ONCOTARGET | 2015年 / 6卷 / 22期
关键词：
Chromosome Section; colorectal cancer; therapy; Ras; EGFR; METASTATIC COLORECTAL-CANCER; MUTATIONS; CETUXIMAB; IRINOTECAN; GROWTH;
D O I：
10.18632/oncotarget.5115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18746 / 18747
页数：2
相关论文
共 50 条
  • [31] Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer
    Rolfo, Christian
    Bronte, Giuseppe
    Passiglia, Francesco
    Papadimitriou, Konstantinos
    Russo, Antonio
    Peeters, Marc
    CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) : 250 - 260
  • [32] Optical imaging predicts tumor response to anti-EGFR therapy
    Helman, Emily E.
    Newman, J. Robert
    Dean, Nichole R.
    Zhang, Wenyue
    Zinn, Kurt R.
    Rosenthal, Eben L.
    CANCER BIOLOGY & THERAPY, 2010, 10 (02) : 166 - 171
  • [33] MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
    Richiardone, Elena
    Al Roumi, Rim
    Lardinois, Fanny
    Giolito, Maria Virginia
    Ambroise, Jerome
    Boidot, Romain
    Drotleff, Bernhard
    Ghesquiere, Bart
    Bellahcene, Akeila
    Bardelli, Alberto
    Arena, Sabrina
    Corbet, Cyril
    CANCER LETTERS, 2024, 598
  • [34] Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?
    Fakih, Marwan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1471 - 1480
  • [35] An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
    Rosati, Gerardo
    Montrone, Michele
    Pacilio, Carmen
    Colombo, Alfredo
    Cicero, Giuseppe
    Paragliola, Fernando
    Vaia, Angelo
    Annunziata, Luigi
    Bilancia, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [36] EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer
    Birkman, Eva-Maria
    Avoranta, Tuulia
    Algars, Annika
    Korkeila, Eija
    Lintunen, Minnamaija
    Lahtinen, Laura
    Kuopio, Teijo
    Ristamaki, Raija
    Carpen, Olli
    Sundstrom, Jari
    HUMAN PATHOLOGY, 2018, 82 : 163 - 171
  • [37] EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
    Algars, A.
    Lintunen, M.
    Carpen, O.
    Ristamaki, R.
    Sundstrom, J.
    BRITISH JOURNAL OF CANCER, 2011, 105 (02) : 255 - 262
  • [38] Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer
    Augustine, T. A.
    Baig, M.
    Sood, A.
    Budagov, T.
    Atzmon, G.
    Mariadason, J. M.
    Aparo, S.
    Maitra, R.
    Goel, S.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 313 - 318
  • [39] Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic colorectal cancer patients
    Jaka, Ane
    Gutierrez-Rivera, Araika
    Ormaechea, Nerea
    Blanco, Jesus
    La Casta, Adelaida
    Sarasqueta, Cristina
    Izeta, Ander
    Tuneu, Anna
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (10) : 751 - 753
  • [40] Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer
    Inoue, Masahiro
    Takahashi, Shin
    Soeda, Hiroshi
    Shimodaira, Hideki
    Watanabe, Mika
    Miura, Koh
    Sasaki, Iwao
    Kato, Shunsuke
    Ishioka, Chikashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1147 - 1155
12345